Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Niloufar Hooshyar"'
Autor:
Niloufar Hooshyar, Banafsheh Yalameha, Mehrnoosh Sedighi, Mohammadreza Khosravifarsani, Parto Nasri
Publikováno v:
Journal of Preventive Epidemiology, Vol 4, Iss 1, Pp e08-e08 (2019)
Externí odkaz:
https://doaj.org/article/04225b18904f47c18e412fff862db72c
Autor:
Karim Mowla, Elham Emami, Maryam Biglari Abhari, Sepideh Zununi Vahed, Muhammed Mubarak, Mohammad Bahadoram, Ahmad Reza Maghsoudi, Hamid Nasri, Niloufar Hooshyar
Publikováno v:
Immunopathologia Persa.
Introduction: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that involves multiple organs including the kidneys, skin, joints and serous membranes. Previous studies have shown that elevated Ki-67 indices are correlated with the
Autor:
Maedeh Barahman, Elham Emami, Maryam Biglari Abhari, Elham Ahmadian, Muhammed Mubarak, Mohammad Bahadoram, Ahmad Reza Maghsoudi, Azar Baradaran, Niloufar Hooshyar
Publikováno v:
Immunopathologia Persa. 8:e31369
Introduction: IgA nephropathy (IgAN) regarded as the main type of primary glomerulonephritis globally. It has a diverse clinical course and unpredictable prognosis. Traditionally, clinical and pathological features are conducted to prognosticate the
Autor:
Parto Nasri, Niloufar Hooshyar, Banafsheh Yalameha, Mahsa Akafzadeh Savari, Mohammadreza Khosravifarsani, Saied Mardani, Pegah Noorshargh, Ali Hasanpour Dehkordi, Hamid Nasri, Elnaz Golestaneh, Elham Bijad, Behzad Ghasemi, Nafiseh Nowrouzi
Publikováno v:
Journal of Nephropathology.
Introduction: The administration of iodinated contrast medium is extensive in various imaging techniques including coronary angiography. Objectives: The present investigation was designed to examine the ameliorative effect of clove buds (Syzygium aro
Autor:
Mehrnoosh Sedighi, Parto Nasri, Mohammadreza Khosravifarsani, Masoomeh Hooshmand, Nafiseh Nowrouzi, Rohollah Valizadeh, Semko Ebrahimi, Niloufar Hooshyar, Behzad Ghasemi
Publikováno v:
Immunopathologia Persa, Vol 5, Iss 1, Pp e07-e07 (2019)
Cisplatin is a powerful chemotherapy drug that is administered to treat a wide range of cancers. However, its clinical use is limited due to kidney damage and the reduction in glomerular filtration rate that occurs in 15% to 30% of patients. Several
Autor:
Ramin Tolouian, Niloufar Hooshyar, Behzad Ghasemi, Mohammadreza Khosravifarsani, Parto Nasri, Nafiseh Nowrouzi, Banafsheh Yalameha
Publikováno v:
Immunopathologia Persa, Vol 5, Iss 1, Pp e11-e11 (2019)
Chemotherapeutic agents are still the major and most common therapy to prevent tumor growth. These drugs have various adverse effects in different organs in addition to systemic effects. Finding more specific and effective drugs or new adjuvant thera